ArticleFrontiers in cellular and infection microbiology2025

A broad-spectrum SARS-CoV-2 RBD vaccine with selected high-impact mutations and novel adjuvant induces durable T cell response and broad protection in mice.

Xianying Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.